Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Berta González-Martínez"'
Autor:
Águeda Molinos-Quintana, Anna Alonso-Saladrigues, Blanca Herrero, Teresa Caballero-Velázquez, Víctor Galán-Gómez, Melissa Panesso, Montserrat Torrebadell, Javier Delgado-Serrano, Concepción Pérez de Soto, Anna Faura, Berta González-Martínez, Ana Castillo-Robleda, Cristina Diaz-de-Heredia, Antonio Pérez-Martínez, José María Pérez-Hurtado, Susana Rives, José Antonio Pérez-Simón
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/4dbe78c098c647e1912ae1c76f51711c
Autor:
Águeda Molinos-Quintana, Anna Alonso-Saladrigues, Blanca Herrero, Teresa Caballero-Velázquez, Víctor Galán-Gómez, Melissa Panesso, Montserrat Torrebadell, Javier Delgado-Serrano, Concepción Pérez de Soto, Anna Faura, Berta González-Martínez, Ana Castillo-Robleda, Cristina Diaz-de-Heredia, Antonio Pérez-Martínez, José María Pérez-Hurtado, Susana Rives, José Antonio Pérez-Simón
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
IntroductionLoss of B-cell aplasia (BCA) is a well-known marker of functional loss of CD19 CAR-T. Most relapses and loss of BCA occur in the first months after CD19 CAR-T infusion. In addition, high tumor burden (HTB) has shown to have a strong impac
Externí odkaz:
https://doaj.org/article/eab57116b92a4aee92a3c970d7151e29
Autor:
Isabel Martínez-Romera, Víctor Galán-Gómez, Berta González-Martínez, Pilar Guerra García, Sonsoles San Román Pacheco, Dolores Corral Sánchez, Yasmina Mozo del Castillo, David Bueno Sánchez, Luisa Sisinni, Alba González Guerrero, Serafin Castellano Dámaso, Elena Sánchez Zapardiel, Beatriz Ruz Caracuel, Antonio Balas Pérez, Antonio Pérez-Martínez
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Treatment targeting CD19 by a chimeric antigen receptor expressed on T cells (anti-CD19 CAR-T) has led to a breakthrough in the management and treatment of relapsed and refractory B- cell acute lymphoblastic leukemia (B-ALL). After infusion, the effi
Externí odkaz:
https://doaj.org/article/ce2688322ec946c8a6d1777dae270900
Autor:
María Bravo García-Morato, Lucía del Pino Molina, Juan Manuel Torres Canizales, Teresa del Rosal Rabes, Ana Méndez Echevarría, Berta González Martínez, Eduardo López-Granados, Rebeca Rodríguez Pena
Publikováno v:
Heliyon, Vol 6, Iss 9, Pp e04914- (2020)
X-linked Agammaglobulinemia is a primary immunodeficiency caused by mutations in BTK, a tyrosine kinase essential for B lymphocytes differentiation. Patients usually have very low or absent B lymphocytes and are not able to develop humoral specific r
Externí odkaz:
https://doaj.org/article/04fc731539cf4b4a8042e0cc96974c24
Autor:
Julia Salmerón-Villalobos, Natalia Castrejon-de-Anta, Pilar Guerra-Garcia, Joan Enric Ramis-Zaldivar, Mònica López-Guerra, Sara Mato, Dolors Colomer, Francisco Javier Diaz Crespo, Javier Menarguez, Marta Garrido-Pontnou, Mara Andres, Eugenia Garcia-Fernandez, Margarita Llavador, Gerard Frigola, Noelia Garcia, Blanca Gonzalez-Farre, Idoia Martin-Guerrero, Carmen Garrido-Colino, Itziar Astigarraga, Alba Fernandez, Jaime Verdu-Amorós, Soledad Gonzalez Muñiz, Berta González-Martínez, Verónica Celis, Elías Campo, Olga Balagué, Itziar Salaverria
Post-transplant lymphoproliferative disorders (PTLD) represent a broad spectrum of lymphoid proliferations, frequently associated with Epstein-Barr Virus (EBV) infection. The molecular profile of pediatric monomorphic PTLDs (mPTLD) has not been eluci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9a79d9a39ee967a980f2287f38059d2
http://hdl.handle.net/2445/198383
http://hdl.handle.net/2445/198383
Autor:
Lucía del Pino Molina, Ana Méndez Echevarría, Eduardo López-Granados, María Bravo García-Morato, Juan Torres Canizales, Teresa del Rosal Rabes, Berta González Martínez, Rebeca Rodríguez Pena
Publikováno v:
Heliyon, Vol 6, Iss 9, Pp e04914-(2020)
Heliyon
Heliyon
X-linked Agammaglobulinemia is a primary immunodeficiency caused by mutations in BTK, a tyrosine kinase essential for B lymphocytes differentiation. Patients usually have very low or absent B lymphocytes and are not able to develop humoral specific r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::050de3b14b277cd097b9fff160b08c0b
http://www.sciencedirect.com/science/article/pii/S2405844020317576
http://www.sciencedirect.com/science/article/pii/S2405844020317576
Autor:
Itziar Astigarraga, José Luis Fuster Soler, Miguel Blanquer Blanquer, Lucía Fernández Casanova, Berta González Martínez, Isabel Mirones Aguilar, Alberto M. Borobia, María Vela Cuenca, Mario Muñoz Builes, Jose M. Vagace Valero, Hoi Y. Tong, Jaime Valentín Quiroga, Antonio Pérez-Martínez, Luisa Sisinni, Antonia Pascual Martínez, Adela Escudero López
Publikováno v:
BMJ Open
IntroductionAcute myeloblastic leukaemia (AML) constitutes the second most common haematological malignancy in the paediatric population. Current treatment regimens are based on the administration of polychemotherapy, combining high doses of cytarabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bff96ec9d7ed7e8338324deae0b54d8
https://pubmed.ncbi.nlm.nih.gov/31919123
https://pubmed.ncbi.nlm.nih.gov/31919123
Autor:
Lida Bubuteishvili-Pacaud, Simon Newsome, Berta González Martínez, Joerg Krueger, Andishe Attarbaschi, Theodore W. Laetsch, Jaclyn Davis, Franco Locatelli, Véronique Minard, Shannon L. Maude, Birgit Burkhardt, Cristina Diaz de Heredia Rubio, Jochen Buechner, Rakesh Awasthi
Publikováno v:
Journal of Clinical Oncology. 38:e22504-e22504
e22504 Background: Pediatric/YA pts with r/r B-NHL are rare and have heterogenous, aggressive histology and poor prognosis. We report early results for tisagenlecleucel (anti-CD19 CAR-T cell therapy) in pediatric/YA pts with r/r B-NHL. Methods: BIANC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::045d6cd82373ec2ef3cb69012a1b1d91
https://doi.org/10.1200/jco.2020.38.15_suppl.e22504
https://doi.org/10.1200/jco.2020.38.15_suppl.e22504
Autor:
Carlos Echecopar, Ismael del Val Rey, Víctor Galán-Gómez, Carlos González-Pérez, Yasmina Mozo del Castillo, Berta González Martínez, Antonio Pérez-Martínez
Publikováno v:
Anales de Pediatría (English Edition), Vol 100, Iss 4, Pp 259-267 (2024)
Introduction: Total body irradiation (TBI) is part of the myeloablative conditioning for hematopoietic stem cell transplantation (HSCT) in malignant hematologic disorders. This therapy has recently shown improved survival in acute lymphoblastic leuke
Externí odkaz:
https://doaj.org/article/d4732464c14d4e25897a817e2511a2c8